Skip to main content
SpringerLink
Log in

Dermatika

  • Chapter
Arzneiverordnungs-Report 2017

  • 2091 Accesses

Zusammenfassung

Dermatika zählen in Deutschland zu den verordnungsstärksten Arzneimitteln. Ihre Anwendungsgebiete sind sehr unterschiedlich. Entsprechend heterogen sind die Stoffklassen, die von den Corticosteroidexterna über die dermatologischen Anti mykotika sowie die Wundbehandlungsmittel bis zu den Hautschutz- und Pflegemitteln reichen (Abbildung 25.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahlehoff O, Skov L, Gislason G, Gniadecki R, Iversen L, Bryld LE, Lasthein S, Lindhardsen J, Kristensen SL, Torp-Pedersen C, Hansen PR (2016): Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. J Eur Acad Dermatol Venereol; 29: 1128–1134

    Google Scholar 

  • Alsterholm M, Flytström I, Bergbrant IM, Faergemann J (2010): Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol 90: 52–57

    Google Scholar 

  • Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P et al. (1994): Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30: 977–981

    Google Scholar 

  • Antille C, Saurat JH, Lübbe J (2004): Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 140: 457–460

    Google Scholar 

  • Arican O, Sasmaz S, Ozbulu O (2006): Increased suicidal tendency in a case of psoriasis vulgaris under acitretin treatment. J Eur Acad Dermatol Venerol 20: 464–465

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (1999): Nutzen und Risiken durch Fumarsäure-Ester bei der Therapie der Psoriasis. Dtsch Ärztebl 96: A-721

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2005): Myopathie nach Tacrolimus-Salbe (Protopic®). Dtsch Ärztebl 102: A3138

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2006): Psychiatrische Reaktionen nach Terninafin (Lamisil®). Dtsch Ärztebl 103: A3432

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2011): Multiple aktinische Keratosen (Carcinomata in situ der Haut) nach langjähriger topischer Anwendung von Tacrolimus (Protopic®). Dtsch Ärztebl 108: A545–A546

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2013a): Rhabdomyolyse nach Isotretinoin. Dtsch Ärztebl 110: A 240

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2013b): Nokardiose bei Lymphopenie durch Fumaderm (Aus der UAW-Datenbank). Dtsch Ärztebl 110: A 1220–1221

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2017): Schwere Gewebeschädigungen nach Spülung tiefer Wunden mit Octenisept. (Aus der UAW-Datenbank). Dtsch Ärztebl 114: A-184

    Google Scholar 

  • Atwan A, Ingram JR, Abbott R, Kelson MJ, Pickles T, Bauer A, Piguet V (2016): Oral fumaric acid esters for psoriasis: abridged Cochrane sys-tematic review including GRADE assessments. Br J Dermatol 175: 873–881

    Google Scholar 

  • Aziz Z, Abu SF, Chong NJ (2012): A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns 38: 307–318

    Google Scholar 

  • Balak DMW, Hajdarbegovic E, Bramer WM, Neumann HAM, Thio HB (2017): Progressive mulrifocal leukencephalopathy associated wirh fumaric acid etsres treatment in psoriasis patients. J Eur Acad Dermatol Venereol 2017 Mar 21. Doi: 10.1111/jdv.14236. [Epub ahead of print]

  • Barajas-Nava LA, López-Alcalde J, Roqué i Figuls M, Solà I, Bonfill Cosp X (2013): Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev. 2013 Jun 6;(6):CD008738. doi: 10.1002/14651858.CD008738.pub2

  • Baran R, Kaoukhov A (2005): Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venerol 19: 21–29

    Google Scholar 

  • Bell-Syer SEM, Khan SM, Torgerson DJ (2012): Oral treatments for fungal infections of the skin of the foot. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD003584. DOI: 10.1002/14651858.CD003584.pub2

  • Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA. Multinational Study Group (2003): Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double-blind, parallel group study. Brit Med J 326: 1367–1373

    Google Scholar 

  • Bewley A for the Dermatology Working Group (2008): Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol 158: 917–920

    Google Scholar 

  • Biogen Idec GmbH (2015): Fumaderm®/ Fumaderm® initial (Dimethylfumarat; Ethylhydrogenfumarat, Calciumsalz; Ethylhydrogenfumarat, Magnesiumsalz; Ethylhydrogenfumarat, Zinksalz): Maßnahmen zur Senkung des Risikos einer progressiven multifokalen Leukenzephalopathie (PML): Neue Maßnahmen zur Senkung des Risikos einer PML – vermehrte Überwachung und Absetzen der Therapie. Internet: https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RHB/2015/rhb-fumaderm.html

  • Blauvelt A, Reich K, Tsai TF, Tyring S, Vanaclocha F, Kingo K, Ziv M, Pinter A, Vender R, Hugot S, You R, Mi-lutinovic M, Thaçi D (2017): Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study. J Am Acad Dermatol; 76: 60–69.e9

    Google Scholar 

  • Boguniewicz M, Leung DY (2010): Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125: 4–13

    Google Scholar 

  • Booij MT, van De Kerkhof PC (2011): Acitretin revisited in the era of biologics. J Dermatolog Treat 22: 86–89

    Google Scholar 

  • Braun R (Hrsg.) (2016): Arzneistoff-Profile, Basisinformation über arzneilich wirksame Wirkstoffe. Stammlieferung 1982 mit 1. bis 29. Erg.-Lieferung 2016, Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn

    Google Scholar 

  • Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC, Landthaler M (2005): Dermatologie und Venerologie, 5. Auflage. Springer Medizin Verlag, Heidelberg

    Google Scholar 

  • Brodt HR (2013): Stille – Antibiotikatherapie. Klinik und Praxis der antiinfektiösen Behandlung. 12. Auflage. Schattauer Verlag Stuttgart

    Google Scholar 

  • Bundesministerium für Gesundheit (2015a): Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel-Richtlinie (AM-RL): Anlage XII – Beschlüsse über die Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a des Fünften Buches Sozialgesetzbuch (SGB V) – Apremilast vom: 06.08.2015. BAnz AT 12.10.2015 B2

    Google Scholar 

  • Bundesministerium für Gesundheit (2015b): Bekanntmachung eines Beschlusses des Gemeinsamen Bundes - ausschusses über eine Änderung der Arzneimittel-Richtlinie (AM-RL): Anlage XII – Beschlüsse über die Nutzenbewer-tung von Arzneimitteln mit neuen Wirkstoffen nach § 35a des Fünften Buches Sozialgesetzbuch (SGB V) – Secukinumab vom: 27.11.2015. BAnz AT 29.12.2015 B4

    Google Scholar 

  • Bundesministerium für Gesundheit und Soziale Sicherung (2004): Bekanntmachung des Gemeinsamen Bundesausschusses über eine Änderung der Richtlinien über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel-Richtlinien) vom 15. Juni 2004.

    Google Scholar 

  • BAnz. Nr. 156 (S. 18 661) vom 20.08.2004, https://www.g-ba.de/institution/sys/suche/ergebnis/?suche[suchbegriff]=crinohermal&suche[offset]=0&suche[sortierung]=relevanz&suche[kategorie]=alle

  • Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H (2009): Contact dermatitis due to use of Octenisept(R) in wound care. J Dtsch Dermatol Ges 7: 759–765

    Google Scholar 

  • Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR (2016): New developments in the treatment of rosacea - role of once-daily ivermectin cream. Clin Cosmet Investig Dermatol 9: 71–77

    Google Scholar 

  • Chi CC, Wang SH, Delamere FM, Wojnarowska F, Peters MC, Kanjirath PP (2015): Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database Syst Rev. 2015 Aug 7;8:CD010095. Doi: 10.1002/14651858.CD010095.pub2

  • Christiansen B (1988): Untersuchungen über die Wirksamkeit eines Hautdesinfektionsmittels mit kationenaktivem Zusatz. Zbl Bakt Hyg B 186: 368–374

    Google Scholar 

  • Chroni E, Monastirli A, Tsambaos D (2010): Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf 33: 25–34

    Google Scholar 

  • Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB Jr, Feldman SR (2007): Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol 6: 495–498

    Google Scholar 

  • Crawford F, Young P, Godfrey C, Bell-Syer SEM, Hart R, Brunt E, Russel I (2002): Oral treatments for toenail onychomycosis. Arch Dermatol 138: 811–816

    Google Scholar 

  • Crawford F, Hollis S (2007): Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2007 Jul 18 (3): CD001434

    Google Scholar 

  • Cunningham A, Griffiths P, Leone P, Mindel A, Patel R, Stanberry L, Whitley R (2012): Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol 53: 6–11

    Google Scholar 

  • Cury Martins J, Martins C, Aoki V, Gois AF, Ishii HA, da Silva EM (2015): Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev. 2015 Jul 1; 7: CD009864. doi: 10.1002/14651858.CD009864.pub2

  • Dall’oglio F, D’Amico V, Nasca MR, Micali G (2012): Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol 13: 73–96

    Google Scholar 

  • Darkes MJM, Scott LJ, Goa KL (2003): Terbinafine. A review of its use in onychomycosis in adults. Am J Clin Dermatol 4: 39–65

    Google Scholar 

  • Del Rosso JQ, Pillai R, Moore R (2010): Absence of degradation of tretinoin when benzoyl peroxide is combined with an optimized formulation of tretinoin gel (0.05%). J Clin Aesthet Dermatol 3: 26–28

    Google Scholar 

  • Deutsche Dermatologische Gesellschaft (2011a): Leitlinie zur Therapie der Psoriasis vulgaris – Update 2011. AWMFLeitlinien-Register Nr. 013/001, http://www.awmf.org/uploads/tx_szleitlinien/013-001l_S3_Psoriasis_vulgaris_Therapie_01_abgelaufen.pdf

  • Deutsche Dermatologische Gesellschaft (2011b): Leitlinie zur Behandlung der aktinischen Keratose C44.X. AWMF-Leitlinien-Register Nr. 013/041, http://www.awmf.org/uploads/tx_szleitlinien/013-041l_S1_Aktinische_Keratose_2012-01.pdf

  • Deutsche Dermatologische Gesellschaft (2013): Leitlinie zur Behandlung der Rosazea. AWMF-Leitlinien-Register Nr. 013/065, Entwicklungsstufe S1. http://www.awmf.org/uploads/tx_szleitlinien/013-065l_S1_Rosazea_2014-04.pdf

  • Deutsche Dermatologische Gesellschaft, Deutschsprachige Mykologische Gesellschaft (2008): Tinea der freien Haut. AWMF-Leitlinien-Register Nr. 013-002, http://www.awmf.org/uploads/tx_szleitlinien/013-002-abgelaufen_01.pdf

  • Deutsche Dermatologische Gesellschaft et al. (2015): Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] Entwicklungsstufe: S2k [ICD 10: L20.8, L20.9, L28.0], AWMF-Registernummer: 013-027. http://www.awmf.org/uploads/tx_szleitlinien/013-027l_S2k_Neurodermitis_2015-03.pdf

  • Deutsche Gesellschaft für Phlebologie (2008): Diagnostik und Therapie des Ulcus cruris venosum. AWMF-Leitlinien-Register Nr. 037/009, http://www.awmf.org/uploads/tx_szleitlinien/037-009l_S3_Diagnostik_und_Therapie_des_Ulcus_cruris_venosum_abgelaufen.pdf

  • Diepgen TL, Andersen KE, Chosidow O, Coenraads PJ, Elsner P, English J, Fartasch M, Gimenez-Arnau A, Nixon R, Sasseville D, Agner T (2015): Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges.; 13: e1–e22

    Google Scholar 

  • Dissemond J, Gerber V, Kramer A, Riepe G, Strobal R, Vasel-Biergans A, Eberlein T (2009): Praxisorientierte Empfehlung zur Behandlung kritisch-kolonisierter und lokal infizierter Wunden mit Polihexanid. Wundmanagement 3: 62–68

    Google Scholar 

  • Dissemond J, Augustin M, Eming SA, Goerge T, Horn T, Karrer S. Schumann H, Stücker M, for the working group for wound healing (AGW) of the German Society of Dermatology (DDG) (2014): Modern wound care – practical aspects of non-interventional topical treatment of patients with chronic wounds. J Dtsch Ges Dermatol, published online: 12 May 2014, DOI: 10.1111/ddg.12351, http://onlinelibrary.wiley.com/doi/10.1111/ddg.12351/pdf

  • Dissemond J, Assenheimer B, Bültemann A, Gerber V, Gretener S, Kohler-von Siebenthal E, Koller S, Kröger K, Kurz P, Läuchli S, Münter C, Panfil EM, Probst S, Protz K, Riepe G, Strohal R, Traber J, Partsch H (2016): Kompressionstherapie bei Patienten mit Ulcus cruris venosum. J Dtsch Dermatol Ges: 14: 1073–1089

    Google Scholar 

  • Dobie D, Gray J (2004): Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 89: 74–77

    Google Scholar 

  • Dréno B, Bettoli V, Ochsendorf F, Layton AM, Perez M, Dakovic R, Gollnick H (2014): Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies. Eur J Dermatol 24: 201–209

    Google Scholar 

  • Drucker CR (2012): Update on topical antibiotics in dermatology. Dermatol Ther 25: 6–11

    Google Scholar 

  • Dumville JC, Keogh SJ, Liu Z, Stubbs N, Walker RM, Fortnam M (2015a): Alginate dressings for treating pressure ulcers. Cochrane Database Syst Rev. 2015 May 21; 5: CD011277. doi: 10.1002/14651858.CD011277.pub2

  • Dumville JC, Stubbs N, Keogh SJ, Walker RM, Liu Z (2015b): Hydrogel dressings for treating pressure ulcers. Cochrane Database Syst Rev. 201 Feb 17; 2: CD011226. doi:10.1002/14651858.CD011226.pub2

  • Eberlein T, Assadian O (2010): Clinical use of polihexanide on acute and chronic wounds for antisepsis and decontamination. 23 (Suppl): 45–51

    Google Scholar 

  • Eberlein T, Haemmerle G, Signer M, Gruber Moesenbacher U, Traber J, Mittlboeck M, Abel M, Strohal R (2012): Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds. J Wound Care 21: 12–20

    Google Scholar 

  • Ebner F, Heller A, Rippke F, Tausch I (2002): Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol 3: 427–433

    Google Scholar 

  • Eckhard M, Lengler A, Liersch J, Bretzel RG, Mayser P (2007): Fungal foot infections in patients with diabetes mellitus – results of two independent investigations. Mycoses 50 (Suppl 2): 14–19

    Google Scholar 

  • Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Sidbury R (2014): Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 71: 116–132

    Google Scholar 

  • Eifler-Bollen R, Fluhr JW (2005): Antimikrobiell wirksame Magistralrezepturen. Stellenwert in der Praxis und kritische Anmerkungen. Hautarzt 56: 752–758

    Google Scholar 

  • El Sayed F, Ammoury A, Dhaybi R, Bazex J (2006): Rosaceiform eruption to pimecrolimus. J Am Acad Dermatol 54: 548–550

    Google Scholar 

  • Erbagci Z (2004): Topical therapy for dermatophytoses. Should corticosteroids be included? Am J Clin Dermatol 5: 375–384

    Google Scholar 

  • European Medicines Agency (EMA) (2006): European Medicines Agency recommends cautious use of Protopic/Protopy and Elidel. http://www.emea.europa.eu/pdfs/general/direct/pr/9888206en.pdf

  • European Medicines Agency (EMA) (2009): Committee on herbal Medicinal Products (HMPC) Assessment report on Hamamelis virginiana L, Cortex; Hamamelis virginiana L,Folium, Hamamelis virginiana L. Folium et cortex aut ramunculus destillatum. Verfügbar unter http://www.ema.europa.eu/ema/. Letzter Zugriff 30.05.2016

  • European Medicines Agency (EMA) (2015): Committee on herbal Medicinal Produkts (HMPC) Assessment report on Matricaria recutita L., flos and Matricaria recutita L., aetheroleum. Verfügbar unter http://www.ema.europa.eu/ema/. Letzter Zugriff 30.06.2015

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2010): Topical calcineurin inhibitors: Literature review. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255139.pdf

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2011): Topical calcineurin inhibitors: Literature review addendum. www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeeting-Materials/PediatricAdvisoryCommittee/UCM255140.pdf

  • Ference JD, Last AR (2009): Choosing topical corticosteroids. Am Fam Physician 79: 135–140

    Google Scholar 

  • Fleischer AB jr, Abramovits W, Breneman D, Jaracz E; US/Canada tacrolimus ointment study group (2007): Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J Dermatol Treat 18: 151–157

    Google Scholar 

  • Fluhr JW, Cavallotti C, Berardesca E (2008): Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol 26: 380–386

    Google Scholar 

  • Fluhr JW, Degitz K (2010): Antibiotika, Azelainsäure und Benzoylperoxid in der topische Aknetherapie. J Dtsch Dermatol Ges 8 (Suppl 1): S24–30

    Google Scholar 

  • Fölster-Holst R, Latussek E (2007): Synthetic tannins in dermatology – a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol 24: 296–301

    Google Scholar 

  • Food and Drug Administration (2014): FDA warns of rare but serious hypersensitivity reactions with certain over-thecounter topical acne products. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM402663.pdf

  • Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M; Brimonidine Phase II Study Group (2012): Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol 166: 633–641

    Google Scholar 

  • Fowler JF, Graff O, Hamedani AG (2014): A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy. J Drugs Dermatol 13: 1198–1204

    Google Scholar 

  • Frankel HC, Qureshi AA (2012): Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Am J Clin Dermatol 13: 113–123

    Google Scholar 

  • Franz T, Vögelin E (2012): Aseptic tissue necrosis and chronic inflammation after irrigation of penetrating hand wounds using Octenisept . J Hand Surg Eur 37: 61–64

    Google Scholar 

  • Garnock-Jones KP, Perry CM (2009): Alitretinoin: in severe chronic hand eczema. Drugs 69: 1625–1634

    Google Scholar 

  • Gaspari A, Tyring SK, Rosen T (2009): Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol 8: 467–474

    Google Scholar 

  • Gemeinsamer Bundesausschuss (2017): Richtlinie des Gemeinsamen Bundesausschusses über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel-Richtlinie/AM-RL) in der Fassung vom 18. Dezember 2008/2 2.Januar 2009 veröffentlicht im Bundesanzeiger 2009 Nr. 49a zuletzt geändert am 16. Februar 2017 veröffentlicht BAnz AT 10.04.2017 B1 in Kraft getreten am 15. Mai 2017. https://www.g-ba.de/downloads/62-492-1391/AM-RL_2017-02-16_iK-2017-05-15_AT-10-04-2017-B1.pdf

  • Gethin G, Cowman S, Kolbach DN (2015): Debridement for venous leg ulcers. Cochrane Database Syst Rev. 2015 Sep 14; 9: CD008599. DOI: 10.1002/14651858.CD008599.pub2

  • Gieselbach RJ, Muller-Hansma AH, Wijburg MT, de Bruin-Weller MS, van Oosten BW, Nieuwkamp DJ, Coenjaerts FE, Wattjes MP, Murk JL (2017): Progressive multifocal leukencephalopathy in patients treated with fumaric acid esters: a review of 19 cases. 264:1155-1164

    Google Scholar 

  • Glenn CJ, Kobraei KB, Russo JJ (2011): New-onset psoriasis associated with adalimumab: a report of two cases. Dermatol Online J 17: 15

    Google Scholar 

  • Gloor M (1982): Pharmakologie dermatologischer Externa. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  • Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu Y, Graeber M; Adapalene-BPO Study Group (2009): Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol. 161: 1180–1189

    Google Scholar 

  • Goreshi R, Samrao A, Ehst BD (2012): A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene. J Drugs Dermatol 11: 1422–1426

    Google Scholar 

  • Gorman CR, White SW (2005): Rosaceiform dermatitis as a complication of treatment of facial seborrhoic dermattis with 1% pimecrolimus cream. Arch Dermatol 141: 1168

    Google Scholar 

  • Griffiths CE, Barker JN (2007): Pathogenesis and clinical features of psoriasis. Lancet 370: 263–271

    Google Scholar 

  • Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, Guzzo C, Xia Y, Zhou B, Li S, Dooley LT, Goldstein NH, Menter A; ACCEPT Study Group (2010): Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 362: 118–128

    Google Scholar 

  • Grillo-Ardila CF, Angel-Müller E, Salazar-Díaz LC, Gaitán HG, Ruiz-Parra AI, Lethaby A (2014): Imiquimod for anogenital warts in non-immunocompromised adults. Cochrane Database Syst Rev. 2014 Nov 1; 11: CD010389. doi: 10.1002/14651858.CD010389.pub2

  • Grover C, Khurana A (2012): An update on treatment of onychomycosis. Mycoses 55: 541–551

    Google Scholar 

  • Gupta AK, Daigle D, Foley KA (2015): Network Meta-Analysis of Onychomycosis Treatments. Skin Appendage Disord 1: 74–81

    Google Scholar 

  • Gupta AK, Paquet M, Villanueva E, Brintnell W (2012): Interventions for actinic keratoses. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD004415. DOI: 10.1002/14651858.CD004415.pub2

  • Gupta AK, Cherman AM, Tyring SK (2005): Viral and nonviral uses of imiquimod: A review. J Cut Med Surg 8: 338–352

    Google Scholar 

  • Gupta AK, Joseph WS (2000): Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States. J Am Podiatr Med Assoc 9: 495–501

    Google Scholar 

  • Hahn C, Röseler S, Fritzsche R, Schneider R, Merk HF (1993): Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomaldependent metabolism of the allergen. Contact Dermatitis 28: 81–83

    Google Scholar 

  • Hendriks AG, Keijsers RR, de Jong EM, Seyger MM, van de Kerkhof PC (2013a): Combinations of classical timehonoured topicals in plaque psoriasis: a systematic review. J Eur Acad Dermatol Venereol 27: 399–410

    Google Scholar 

  • Hendriks AG, Keijsers RR, de Jong EM, Seyger MM, van de Kerkhof PC (2013b): Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 27: 931–951

    Google Scholar 

  • Heng YK, Tan KT, Sen P, Chow A, Leo YS, Lye DC, Chan RK (2013): Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance. Int J Dermatol 52: 876–881

    Google Scholar 

  • Hengge UR, Ruzicka T, Schartz RA, Cork MJ (2006): Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54: 1–15

    Google Scholar 

  • Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN (2003): Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 149: 363–369

    Google Scholar 

  • Hoffmann R, Happle R (2000): Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment. Eur J Dermatol 10: 410–417

    Google Scholar 

  • Hornstein OP, Nürnberg E (Hrsg) (1985): Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Georg Thieme Verlag, Stuttgart New York

    Google Scholar 

  • Hund M, Sinkgraven R, Rzany B (2004): Randomisierte, plazebokontrollierte klinische Doppelblindstudie zur Wirksamkeit und Verträglichkeit der oralen Therapie mit Methantheliniumbromid (Vagantin ) bei fokaler Hyperhidrose. J Dtsch Dermatol Ges 2: 343–349

    Google Scholar 

  • Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG) (2017): IQWiG-Berichte – Nr. 515 Secukinumab (Plaque-Psoriasis) – Nutzenbewertung gemäß § 35a SGB V (neue wissenschaftliche Erkenntnisse). Auftrag A17-08, Version 1.0 Stand 30.05.2017

    Google Scholar 

  • Iorizzo M, Piraccini BM, Tosti A (2010): Today’s treatments options for onychomycosis. J Dtsch Dermatol Ges 8: 875–879

    Google Scholar 

  • Iorizzo M, Hartmane I, Derveniece A, Mikazans I (2016): Ciclopirox 8% HPCH nail lacquer in the treatment of mild-to-moderate onychomycosis: A randomized, double-blind amorolfine controlled study using a blinded evaluator. Skin Appendage Disord 1: 134–140. doi: 10.1159/000441569. Erratum in: Skin Appendage Disord 2016 May; 1(4): 168

  • Jacobi A, Mayer A, Augustin M (2015): Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review. Dermatol Ther (Heidelberg); 5: 1–18

    Google Scholar 

  • Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB (1999): Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 5: 2006–2011

    Google Scholar 

  • Koburger T, Hübner NO, Braun M, Siebert J, Kramer A (2010): Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother; 65: 1712–1719

    Google Scholar 

  • Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, Berger M, van der Wouden JC (2012): Interventions for impetigo. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD003261. DOI: 10.1002/14651858.CD003261.pub3

  • Koo JYM (2005): New developments in topical sequential therapy for psoriasis. Skin Therapy Lett 10: 1–4

    Google Scholar 

  • Korting HC (1995): Dermatotherapie: ein Leitfaden. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  • Krug M, Oji V, Traupe H, Berneburg M (2009): Ichthyoses – Part 1: Differential diagnosis of vulgar ichthyoses and therapeutic options. J Dtsch Dermatol Ges 7: 511–519

    Google Scholar 

  • Küster W, Bohnsack K, Rippke F, Upmeyer HJ, Groll S, Traupe H (1998): Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 196: 217–222

    Google Scholar 

  • Küster W (2006): Ichthyosen: Vorschläge für eine verbesserte Therapie. Dtsch Ärztebl 103: A1684–A1689

    Google Scholar 

  • Kujath P, Michelsen A (2008): Wunden – von der Physiologie zum Verband. Dtsch Ärztebl 105: 239–248

    Google Scholar 

  • Kwok CS, Gibbs S, Bennen C, Holland R, Abbott R (2012): Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews 2012, Issue 9, Art, No CD00178L DOr: 10.1002/14651858.CD00178Lpub3

  • Lachapelle JM (2014): A comparison of the irritant and allergenic properties of antiseptics. Eur J Dermatol 24: 3–9

    Google Scholar 

  • Langer A, Rogowski W (2009): Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research 2009, 9: 115 (DOI: 10.1186/1472-6963-9-115)

  • Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigur-geirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group (2014): Secukinumab in plaque psoriasis--results of two phase 3 trials. N Engl J Med; 371: 326–338

    Google Scholar 

  • Langley RG, Lebwohl M, Krueger GG, Szapary PO, Wasfi Y, Chan D, Hsu MC, You Y, Poulin Y, Korman N, Prinz JC, Reich K; PHOENIX 2 Investigators (2015): Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up. Br J Dermatol 172: 1371–1383

    Google Scholar 

  • Langner A, Sheehan-Dare R, Layton A (2007): A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol 21: 311–319

    Google Scholar 

  • Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Ågren MS (2007): Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 15: 2–16

    Google Scholar 

  • Lawee D, Rosenthal D, Aoki FY, Portnoy J (1988): Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study. CMAJ 138: 329–333

    Google Scholar 

  • Layton AM, Schaller M, Homey B, Hofmann MA, Bewley AP, Lehmann P, Nohlgård C, Sarwer DB, Kerrouche N, Ma YM (2015): Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study. J Eur Acad Dermatol Venereol: 29: 2405-2410

    Google Scholar 

  • Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R (2005): Treatment options – development of consensus guidelines. J Eur Acad Dermatol Venereol 19 (suppl 1): 25–33

    Google Scholar 

  • Legendre L, Barnetche T, Mazereeuw-Hautier J, Meyer N, Murrell D, Paul C (2015): Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. J Am Acad Dermatol 72: 992–1002

    Google Scholar 

  • Lohde H, Stahlmann R (Hrsg.) (2004): Nadifloxacin – irrationaler Einsatz eines Fluorchinolons zur lokalen Aknetherapie. Zeitschr Chemother 25: 27–29

    Google Scholar 

  • Løkkevik E, Skovlund E, Reitan JB, Hannisdal E, Tanum G (1996): Skin treatment with Bepanthen cream versus no cream during radiotherapy. Acta Oncol 35: 1021–1026

    Google Scholar 

  • Longstaff E, von Krogh G (2001): Condyloma eradication: self-therapy with 0.15–0.5% podophyllotoxin versus 20–25% podophyllin preparations--an integrated safety assessment. Regul Toxicol Pharmacol 33: 117–137

    Google Scholar 

  • Lopaschuk CR (2013): New approach to managing genital warts. Can Fam Physician 59: 731–736

    Google Scholar 

  • Luger TA, Loske KD, Elsner P, Kapp A, Kerscher M, Korting HC, Krutmann J, Niedner R, Röcken M, Ruzicka T, Schwarz T (2004): Topische Dermatotherapie mit Glukokortikoiden – Therapeutischer Index. JDDG 7, Band 2: 629–634

    Google Scholar 

  • Magin P, Sullivan J (2010): Suicide attempts in people taking isotretinoin for acne. Br Med J 341: c5866

    Google Scholar 

  • Mahil SK, Andrews TC, Brierley C, Barker JN, Smith CH (2013): Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature. J Dermatolog Treat 24: 38–49

    Google Scholar 

  • Mayser P, Freund V, Budihardja D (2009): Toenail onychomycosis in diabetic patients: issues and managemant. Am J Clin Dermatol 10: 211–220

    Google Scholar 

  • McClellan KJ, Noble S (2000): Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 1: 191–199

    Google Scholar 

  • McNeil JC, Hulten KG, Kaplan SL, Mason EO (2014): Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother 58: 2878–2883

    Google Scholar 

  • Menezes de Padua CA, Schnuch A, Nink K, Pfahlberg A, Uter W (2008): Allergic contact dermatitis to topical drugs – epidemiological risk assessment. Pharmacoepidemiol Drug Saf 17: 813–821

    Google Scholar 

  • Meng Y, Dongmei L, Yanbin P, Jinju F, Meile T, Binzhu L, Xiao H, Ping T, Jianmin L (2014): Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis. Clin Exp Dermatol 39: 696–707

    Google Scholar 

  • Merk HF (2007): Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 46: 12–18

    Google Scholar 

  • Moore AY (2009): Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatolog Treat 20: 328–335

    Google Scholar 

  • Moore ZEH, Cowman S (2013): Wound cleansing for pressure ulcers. Cochrane Database Syst Rev. 2013, Issue 3: CD004983. doi: 10.1002/14651858.CD004983.pub3

  • Mosti G (2013): Wound care in venous ulcers. Phlebology 28 (Suppl 1): 79–85

    Google Scholar 

  • Mrowietz U, Szepietowski JC, Loewe R, van de Kerkhof P, Lamarca R, Ocker WG, Tebbs VM, Pau-Charles I (2017): Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm(®) – and placebo-controlled trial (BRIDGE). Br J Dermatol; 176: 615–623

    Google Scholar 

  • Müller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, Rzany B (2013): Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol; 27: 1278–1284

    Google Scholar 

  • Müller G, Kramer A (2008): Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. Antimicrob Chemother 61: 1281–1287

    Google Scholar 

  • Muller A, Talon D, Potier A, Belle E, Cappelier G, Bertrand X (2005): Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Critical Care 9: R246–R250

    Google Scholar 

  • Niedner R (1998): Kortikoide in der Dermatologie. UNI-MED Verlag, Bremen

    Google Scholar 

  • Niedner R, Ziegenmeyer J (Hrsg) (1992): Dermatika. Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Nieuwkamp DJ, Murk JL, van Oosten BW, Cremers CH, Killestein J, Viveen MC, Van Hecke W, Frijlink DW, Wattjes MP (2015): PML in a patient without severe lymphocytopenia receiving dimethyl fumarate. N Engl J Med 372: 1474–1476

    Google Scholar 

  • O’Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R (2014): Antibiotics and antiseptics for venous leg ulcers. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD003557. DOI: 10.1002/14651858.CD003557.pub5

  • Palfreyman S, Nelson EA, Michaels JA (2007): Dressings for venous leg ulcers: systematic review and mety-analysis. Br Med J 335: 244–248

    Google Scholar 

  • Paller AS, Lebwohl M, Fleischer AB jr, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ; US/Canada Tacrolimus Ointment Study Group (2005): Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 52: 810–822

    Google Scholar 

  • Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE (2015): Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). J Am Acad Dermatol; 73: 37–49

    Google Scholar 

  • Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ, for the Psoriasis Foundation (2007): National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143: 239–242

    Google Scholar 

  • Patel B, Siskin S, Krazmien R, Lebwohl M (1998): Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 38: 1010–1011

    Google Scholar 

  • Patel R, Alderson S, Geretti A, Nilsen A, Foley E, Lautenschlager S, Green J, van der Meijden W, Gomberg M, Moi H; IUSTI/WHO Europe (2011): European guideline for the management of genital herpes, 2010. Int J STD AIDS 22: 1–10

    Google Scholar 

  • Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B (2009): European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23 (Suppl 2): 1–70

    Google Scholar 

  • Paul C, Cather J, Gooderham M, Poulin Y, Mrowietz U, Ferrandiz C, Crowley J, Hu C, Stevens RM, Shah K, Day RM, Girolomoni G, Gottlieb AB (2015): Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ES-TEEM 2). Br J Dermatol; 173: 1387–1399

    Google Scholar 

  • Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M (2010): Alitretinoin for the treatment of severe chronic hand eczema. Health Technol Assess 14 Suppl 1: 39–46

    Google Scholar 

  • Peserico A, Städtler G, Sebastian M, Fernandez RS, Vick K, Bieber T (2008): Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 158: 801–807

    Google Scholar 

  • Piatkowski A, Drummer N, Andriessen A, Ulrich D, Pallua N (2011): Randomized controlled single center study comparing a polyhexanide containing bio-cellulose dressing with silver sulfadiazine cream in partial-thickness dermal burns. 37: 800–804

    Google Scholar 

  • Post B, Jänner M (1971): Zur Indikation der Gerbstofftherapie in der Dermatologie. Klinische Erfahrungen mit Tannosynt. Ther Ggw 110: 1477–1494

    Google Scholar 

  • Qureshi AA, Fischer MA (2006): Topical calcineurin inhibitors for atopic dermatitis - Balancing clinical benefit and possible risks. Arch Dermatol 142: 633–637

    Google Scholar 

  • Rahimi H, Mara T, Costella J, Speechley M, Bohay R (2012): Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and metaanalysis. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 618–627

    Google Scholar 

  • Ramos-e-Silva M, Oliveira Lima CM, Casz Schechtman R, Moritz Trope B, Carneiro S (2012): Systemic mycoses in immunodepressed patients (AIDS) Clin Dermatol 30: 616–627

    Google Scholar 

  • Rashaan ZM, Krijnen P, Klamer RR, Schipper IB, Dekkers OM, Breederveld RS (2014): Nonsilver treatment vs. silver sulfadiazine in treatment of partial-thickness burn wounds in children: a systematic review and meta-analysis. Wound Repair Regen 22: 473–482

    Google Scholar 

  • Rathi SK, D’Souza P (2012): Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol 57: 251–259

    Google Scholar 

  • Reich K, Gooderham M, Green L, Bewley A, Zhang Z, Khanskaya I, Day RM, Goncalves J, Shah K, Piguet V, Soung J (2017): The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE). J Eur Acad Dermatol Venereol. 31: 507–517

    Google Scholar 

  • Ring J, Fröhlich HH (1985): Wirkstoffe in der dermatologischen Therapie, 2. Aufl, Springer-Verlag, Berlin Heidelberg

    Google Scholar 

  • Rotta I, Sanchez A, Gonçalves PR, Otuki MF, Correr CJ (2012): Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. Br J Dermatol 166: 927–933

    Google Scholar 

  • Ruzicka T (2006): Methylprednisolone aceponate in eczema and other inflammatory skin disorders – a clinical update. Int J Clin Pract 60: 85–92

    Google Scholar 

  • Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, de Lemos JA, Daoud Y, Blankenship D, Kazi S, Kaplan DH, Friedewald VE, Menter A (2011): Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. JAMA 306: 864–871

    Google Scholar 

  • Saco M, Howe N, Nathoo R, Cherpelis B (2016): Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Dermatol Online J: 22. pii: 13030/qt7ph5v17z.

    Google Scholar 

  • Samrao A, Cockerell CJ (2013): Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents. Am J Clin Dermatol 14: 273–237

    Google Scholar 

  • Sapijaszko MJA (2005): Imiquimod 5% cream (Aldara ) in the treatment of basal cell carcinoma. Skin Ther Lett 10: 2–5

    Google Scholar 

  • Saraswat A (2014): Ethical use of topical corticosteroids. Indian J Dermatol 59: 469–472

    Google Scholar 

  • Schäfer-Korting M, Schmid MH, Korting HC (1996): Topical glucocorticoids with improved risk-benefit ratio. Drug Safety 14: 375–385

    Google Scholar 

  • Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY (2010): Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125: 39–49

    Google Scholar 

  • Schöfer H, Simonsen L (2010): Fusidic acid in dermatology: an updated review. Eur J Dermatol 20: 6–15

    Google Scholar 

  • Schülke & Mayr GmbH (2011): Octenisept – Ödematöse Schwellungen und Gewebeschädigungen nach Wundspülungen unter Druck – Warnung vor nicht bestimmungsgemäßem Gebrauch Rote Hand Brief 21. Januar 2011, http://www.akdae.de/Arzneimittelsicherheit/RHB/20110127.pdf

  • Schulze-Dirks A, Frosch PJ (1988): Kontaktallergie auf Dexpanthenol. Hautarzt 39: 375–377

    Google Scholar 

  • Shim J, Lanier J, Qui MK (2014): Clinical inquiry: what is the best treatment for impetigo? J Fam Pract 63: 333–335

    Google Scholar 

  • Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR (2011): Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: The Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol 67: e179–185

    Google Scholar 

  • Singal A, Khanna D (2011): Onychomycosis: Diagnosis and management. Indian J Dermatol Venereol Leprol 77: 659–672

    Google Scholar 

  • Smith F, Dryburgh N, Donaldson J, Mitchell M (2013): Debridement for surgical wounds. Cochrane Database Syst Rev. 2013 Sep 5; 9: CD006214. doi: 10.1002/14651858.CD006214.pub4.

  • Solares CA, Batra PS, Hall GS, Citardi MJ (2006): Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 27: 161–165

    Google Scholar 

  • Sticherling M, Mrowietz U, Augustin M, Thaçi D, Melzer N, Hentschke C, Kneidl J, Sieder C, Reich K (2017): Secukinumab is Superior to Fumaric Acid Esters in Treating Subjects with Moderate to Severe Plaque Psoriasis who are Naïve to Systemic Treatments: Results from the Randomized Controlled PRIME Trial. Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15707. [Epub ahead of print]

  • Stockfleth E, Beti H, Orasan R, Grigorian F, Mescheder A, Tawfik H, Thielert C (2008): Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Br J Dermatol 158: 1329–1338

    Google Scholar 

  • Stockfleth E, Kerl H, Zwingers T, Willers C (2011): Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Br J Dermatol 165: 1101–1108

    Google Scholar 

  • Stockfleth E, Sibbring GC, Alarcon I (2016): New topical treatment options for actinic keratosis: A systematic review. Acta Derm Venereol 96: 17–22

    Google Scholar 

  • Strober B, Gottlieb AB, Sherif B, Mollon P, Gilloteau I, McLeod L, Fox T, Mordin M, Gnanasakthy A, Papavassilis C, Lebwohl MG (2017): Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept. J Am Acad Dermatol; 76: 655–661

    Google Scholar 

  • Strömberg HE, Ågren MS (1984): Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 111: 461–468

    Google Scholar 

  • Subissi A, Monti D, Togni G, Mailland F (2010): Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs 70: 2133–2152

    Google Scholar 

  • Sunderkötter C, Herrmann M, Jappe U (2006): Antimikrobielle Therapie in der Dermatologie. J Dtsch Dermatol Ges 4: 10–26

    Google Scholar 

  • Sundström A, Alfredsson L, Sjölin-Forsberg G, Gerdén B, Bergman U, Jokinen J (2010): Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. Br Med J 341: c5812

    Google Scholar 

  • Swanson N, Abramovits W, Berman B, Kulp J, Rigel DS, Levy S (2010): Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. J Am Acad Dermatol 62: 582–590

    Google Scholar 

  • Tabara K, Szewczyk AE, Bienias W, Wojciechowska A, Pastuszka M, Oszukowska M, Kaszuba A (2015): Amorolfine vs. ciclopirox-lacquers for the treatment of onychomycosis. Postepy Dermatol Alergol 32: 40–45

    Google Scholar 

  • Tadicherla S, Ross K, Shenefelt PD, Fenske NA (2009): Topical corticosteroids in dermatology. J Drugs Dermatol 8: 1093–1105

    Google Scholar 

  • Taieb A, Ortonne JP, Ruzicka T, Roszkiewicz J, Berth-Jones J, Peirone MH, Jacovella J; Ivermectin Phase III study group (2015): Superiority of ivermectin 1% cream over metronidazole 0•75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol: 172: 1103–1110

    Google Scholar 

  • Tatti S, Swinehart JM, Thielert C, Tawfik H, Mescheder A, Beutner KR (2008): Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial. Obstet Gynecol 111: 1371–1379

    Google Scholar 

  • Thaçi D, Schöfer H (2005): Topische Antibiotika zur Therapie von Hautinfektionen. Hautarzt 56: 381–396

    Google Scholar 

  • Thaçi D, Blauvelt A, Reich K, Tsai TF, Vanaclocha F, Kingo K, Ziv M, Pinter A, Hugot S, You R, Milutinovic M (2015): Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial. J Am Acad Dermatol; 73: 400–409

    Google Scholar 

  • Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, Liu Y, Graeber M, Kang S; Adapalene-BPO Study Group (2007): Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol 57: 791–799

    Google Scholar 

  • Thielitz A, AbdeL-Naser MB, Fluhr JW, Zouboulis CC, Gollnick H (2010): Topische Retinoide bei Akne – eine evidenzbasierte Übersicht. J Dtsch Dermatol Ges 8 (Suppl 1): S15–S23

    Google Scholar 

  • Tzellos T, Kyrgidis A, Zouboulis CC (2013): Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol 27: 622–627

    Google Scholar 

  • Udompataikul M, Limpa-o-vart D (2012): Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study. J Drugs Dermatol 11: 366–374

    Google Scholar 

  • Uter W, Geier J, Fuchs T (2000): Contact allergy to polidocanol, 1992 to 1999. J All Clin Immunol 106: 1203–1204

    Google Scholar 

  • Valente Duarte de Sousa IC (2014): Novel pharmacological approaches for the treatment of acne vulgaris. Expert Opin Investig Drugs 2: 1–22

    Google Scholar 

  • van de Kerkhof PC, Kragballe K, Segaert S, Lebwohl M; International Psoriasis Council (2011): Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol 25: 1130–139

    Google Scholar 

  • van Steensel MAM (2007): Emerging drugs for ichthyosis. Expert Opin Emerg Drugs 12: 647–656

    Google Scholar 

  • van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L (2015): Interventions for rosacea. Cochrane Database Syst Rev. 2015 Apr 28;4:CD003262. doi: 10.1002/14651858.CD003262.pub5

  • Vegter S, Tolley K (2014): A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe. PLoS One 2014 Jun 3; 9: e96829

    Google Scholar 

  • von Krogh G (1978): Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study. Acta Derm Venereol 58: 163–168

    Google Scholar 

  • Walluf-Blume D (1991): Aufbereitung und Nachzulassung von OTC-Arzneimitteln in den USA 1990. Pharm Ind 53: 152–158

    Google Scholar 

  • Wananukul S, Limpongsanuruk W, Singalavanija S, Wisuthsarewong W (2006): Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J Med Assoc Thai 89: 1654–1658

    Google Scholar 

  • Weidinger S, Novak N (2016): Atopic dermatitis. Lancet 387: 1109–1122

    Google Scholar 

  • Wilkinson JD (1998): Fusidic acid in dermatology. Br J Dermatol 139 (Suppl 53): 37–40

    Google Scholar 

  • Williams H (2002): New treatments for topic dermatitis. Brit Med J 324: 1533–1534

    Google Scholar 

  • Willy C, Stichling M, Müller M, Gatzer R, Kramer A, , Vogt D (2016): Akute Maßnahmen beim „limb salvage“-salvage”- Prozedere Teil 2. Debridement, Lavagetechniken und antiinfektiöse Strategien. Unfallchirurg 119: 388–399

    Google Scholar 

  • Wohlrab J (2006): Basistherapie der Psoriasis vulgaris. Hautarzt 57: 661–665

    Google Scholar 

  • Wong RK, Bensadoun RJ, Boers-Doets CB, Bryce J, Chan A, Epstein JB, Eaby-Sandy B, Lacouture ME (2013): Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer 21: 2933–2948

    Google Scholar 

  • Worret WI, Fluhr JW (2006): Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges 4: 293–300

    Google Scholar 

  • Wright JB, Lam K, Burrell RE (1998): Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am J Infect Control 26: 572–577

    Google Scholar 

  • Yan J, Chen SL, Wang HN, Wu TX (2006): Meta-analysis of 5% imiquimod amd 0,5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology 213: 218–223

    Google Scholar 

  • Yin Z, Xu J, Luo D (2011): Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis. J Biomed Res; 25: 385–391

    Google Scholar 

  • Yates JE, Phifer JB, Flake D (2009): Clinical inquiries. Do nonmedicated topicals relieve childhood eczema? J Fam Pract 58: 280–281

    Google Scholar 

  • Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, Bowe WP, Graber EM, Harper JC, Kang S, Keri JE, Leyden JJ, Reynolds RV, Silverberg NB, Stein Gold LF, Tollefson MM, Weiss JS, Dolan NC, Sagan AA, Stern M, Boyer KM, Bhushan R (2016): Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 74: 945-973.e33

    Google Scholar 

  • Zhu TH, Nakamura M, Abrouk M, Farahnik B, Koo J, Bhutani T (2016): Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review. J Dermatolog Treat 2: 1–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. PharmaFacts, Gesellschaft zur Forschung und Beratung im Bereich Arzneimittelversorgung mbH, Wilhelmstraße 1e, 79098, Freiburg, Deutschland

    Judith Günther

  2. Institut für Pharmakologie der Universität zu Köln, Gleueler Straße 24, 50924, Köln, Deutschland

    Uwe Fricke

Authors
  1. Judith Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uwe Fricke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Judith Günther .

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg, Deutschland

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln, Deutschland

    Dieter Paffrath

  3. Arzneimittelkommission der deutschen Ärzteschaft, Herbert-Lewin-Platz 1, 10623, Berlin, Deutschland

    Wolf-Dieter Ludwig

  4. Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178, Berlin, Deutschland

    Jürgen Klauber

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Germany

About this chapter

Cite this chapter

Günther, J., Fricke, U. (2017). Dermatika. In: Schwabe, U., Paffrath, D., Ludwig, WD., Klauber, J. (eds) Arzneiverordnungs-Report 2017. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54630-7_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54630-7_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54629-1

  • Online ISBN: 978-3-662-54630-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation